Archives: Announcements

Announcements

Our science was presented at the 2022 ASTRO Annual Meeting in San Antonio from October 23-26.


Presidential Symposium: The State of the Art in Digital Pathology and AI: Progress in Prostate Cancer
Presented by: Osama Mohamad, MD (Sunday, October 23, 2022 at 12:15 PM)
UroToday Article

Plenary Session: Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Presented by: Jonathan D. Tward, MD, PhD, FASTRO (Monday, October 24, 2022 at 1:46 PM)
UroToday Article

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.

Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood of success and the lowest likelihood of toxicity. International standards for prognostication rely on non-specific and semi-quantitative tools, commonly leading to over- and under-treatment. Tissue-based molecular biomarkers have attempted to address this, but…

Nature DM